{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:37:16Z","timestamp":1784162236802,"version":"3.55.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10875-020-00805-7","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T13:03:57Z","timestamp":1594127037000},"page":"791-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Inborn Errors of Adaptive Immunity in Down Syndrome"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-8405","authenticated-orcid":false,"given":"Ruud H.J.","family":"Verstegen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike A.A.","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"805_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/pai.13133","volume":"31","author":"RHJ Verstegen","year":"2020","unstructured":"Verstegen RHJ, Chang KJJ, Kusters MAA. Clinical implications of immune-mediated diseases in children with Down syndrome. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2020;31:117\u201323. https:\/\/doi.org\/10.1111\/pai.13133.","journal-title":"Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology"},{"key":"805_CR2","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1542\/peds.2008-1440","volume":"123","author":"LA Schieve","year":"2009","unstructured":"Schieve LA, Boulet SL, Boyle C, Rasmussen SA, Schendel D. Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics. 2009;123:e253\u201360. https:\/\/doi.org\/10.1542\/peds.2008-1440.","journal-title":"Pediatrics"},{"key":"805_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2431-14-103","volume":"14","author":"RH Verstegen","year":"2014","unstructured":"Verstegen RH, van Hout RW, de Vries E. Epidemiology of respiratory symptoms in children with Down syndrome: a nationwide prospective web-based parent-reported study. BMC Pediatr. 2014;14:103. https:\/\/doi.org\/10.1186\/1471-2431-14-103.","journal-title":"BMC Pediatr"},{"key":"805_CR4","doi-asserted-by":"publisher","unstructured":"Manikam L et al. Respiratory tract infection-related healthcare utilisation in children with Down\u2019s syndrome. Infection. 2020. https:\/\/doi.org\/10.1007\/s15010-020-01408-5 .","DOI":"10.1007\/s15010-020-01408-5"},{"key":"805_CR5","doi-asserted-by":"publisher","unstructured":"Beckhaus AA, Castro-Rodriguez JA. Down syndrome and the risk of severe RSV infection: a meta-analysis. Pediatrics. 2018. https:\/\/doi.org\/10.1542\/peds.2018-0225.","DOI":"10.1542\/peds.2018-0225"},{"key":"805_CR6","doi-asserted-by":"publisher","unstructured":"Englund A, Jonsson B, Zander CS, Gustafsson J, Anneren G. Changes in mortality and causes of death in the Swedish Down syndrome population. Am J Med Genet. 2013;A161a:642\u20139. https:\/\/doi.org\/10.1002\/ajmg.a.35706.","DOI":"10.1002\/ajmg.a.35706"},{"key":"805_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1017\/S0012162205000319","volume":"47","author":"SM Day","year":"2005","unstructured":"Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol. 2005;47:171\u20136.","journal-title":"Dev Med Child Neurol"},{"key":"805_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13023-018-0989-x","volume":"14","author":"A Guffroy","year":"2019","unstructured":"Guffroy A, Dieudonn\u00e9 Y, Uring-Lambert B, Goetz J, Alembik Y, Korganow AS. Infection risk among adults with down syndrome: a two group series of 101 patients in a tertiary center. Orphanet J Rare Dis. 2019;14:15. https:\/\/doi.org\/10.1186\/s13023-018-0989-x.","journal-title":"Orphanet J Rare Dis"},{"key":"805_CR9","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1038\/ncomms5654","volume":"5","author":"SI Nikolaev","year":"2014","unstructured":"Nikolaev SI, Garieri M, Santoni F, Falconnet E, Ribaux P, Guipponi M, et al. Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations. Nat Commun. 2014;5:4654. https:\/\/doi.org\/10.1038\/ncomms5654.","journal-title":"Nat Commun"},{"key":"805_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2016.23","volume":"18","author":"H Hasle","year":"2016","unstructured":"Hasle H, Friedman JM, Olsen JH, Rasmussen SA. Low risk of solid tumors in persons with Down syndrome. Genetics in medicine: official journal of the American College of Medical Genetics. 2016;18:1151\u20137. https:\/\/doi.org\/10.1038\/gim.2016.23.","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"key":"805_CR11","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.3389\/fimmu.2018.03058","volume":"9","author":"D Satge","year":"2018","unstructured":"Satge D, Seidel MG. The pattern of malignancies in Down syndrome and its potential context with the immune system. Front Immunol. 2018;9:3058. https:\/\/doi.org\/10.3389\/fimmu.2018.03058.","journal-title":"Front Immunol"},{"key":"805_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1542\/peds.2011-1605","volume":"128","author":"MJ Bull","year":"2011","unstructured":"Bull MJ. Health supervision for children with Down syndrome. Pediatrics. 2011;128:393\u2013406. https:\/\/doi.org\/10.1542\/peds.2011-1605.","journal-title":"Pediatrics"},{"key":"805_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297. https:\/\/doi.org\/10.1371\/journal.pmed.0030297.","journal-title":"PLoS Med"},{"issue":"Suppl 6","key":"805_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/jdv.15822","volume":"33","author":"S Veraldi","year":"2019","unstructured":"Veraldi S, Guanziroli E, Benzecry V, Nazzaro G. Hidradenitis suppurativa in patients with Down syndrome. J Eur Acad Dermatol Venereol. 2019;33(Suppl 6):34\u20135. https:\/\/doi.org\/10.1111\/jdv.15822.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"805_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000890","volume":"5","author":"CM Foley","year":"2019","unstructured":"Foley CM, Deely DA, MacDermott EJ, Killeen OG. Arthropathy of Down syndrome: an under-diagnosed inflammatory joint disease that warrants a name change. RMD Open. 2019;5:e000890. https:\/\/doi.org\/10.1136\/rmdopen-2018-000890.","journal-title":"RMD Open"},{"key":"805_CR16","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","volume":"46","author":"F Lai","year":"1989","unstructured":"Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46:849\u201353.","journal-title":"Arch Neurol"},{"key":"805_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15:135\u201347. https:\/\/doi.org\/10.1038\/s41582-018-0132-6.","journal-title":"Nat Rev Neurol"},{"key":"805_CR18","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.neurobiolaging.2015.05.016","volume":"36","author":"DM Wilcock","year":"2015","unstructured":"Wilcock DM, Hurban J, Helman AM, Sudduth TL, McCarty KL, Beckett TL, et al. Down syndrome individuals with Alzheimer\u2019s disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer\u2019s disease. Neurobiol Aging. 2015;36:2468\u201374. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.05.016.","journal-title":"Neurobiol Aging"},{"key":"805_CR19","doi-asserted-by":"publisher","unstructured":"Tangye SG, et al. Human Inborn Errors of Immunity: 2019 Update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020. https:\/\/doi.org\/10.1007\/s10875-019-00737-x.","DOI":"10.1007\/s10875-019-00737-x"},{"key":"805_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fgene.2018.00125","volume":"9","author":"MC Pelleri","year":"2018","unstructured":"Pelleri MC, Cattani C, Vitale L, Antonaros F, Strippoli P, Locatelli C, et al. Integrated quantitative transcriptome maps of human trisomy 21 tissues and cells. Front Genet. 2018;9:125. https:\/\/doi.org\/10.3389\/fgene.2018.00125.","journal-title":"Front Genet"},{"key":"805_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2350-7-24","volume":"7","author":"CM Li","year":"2006","unstructured":"Li CM, Guo M, Salas M, Schupf N, Silverman W, Zigman WB, et al. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC medical genetics. 2006;7:24. https:\/\/doi.org\/10.1186\/1471-2350-7-24.","journal-title":"BMC medical genetics"},{"key":"805_CR22","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/gb-2005-6-13-r107","volume":"6","author":"R Mao","year":"2005","unstructured":"Mao R, Wang X, Spitznagel EL Jr, Frelin LP, Ting JC, Ding H, et al. Primary and secondary transcriptional effects in the developing human down syndrome brain and heart. Genome Biol. 2005;6:R107. https:\/\/doi.org\/10.1186\/gb-2005-6-13-r107.","journal-title":"Genome Biol"},{"key":"805_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature13200","volume":"508","author":"A Letourneau","year":"2014","unstructured":"Letourneau A, Santoni FA, Bonilla X, Sailani MR, Gonzalez D, Kind J, et al. Domains of genome-wide gene expression dysregulation in Down\u2019s syndrome. Nature. 2014;508:345\u201350. https:\/\/doi.org\/10.1038\/nature13200.","journal-title":"Nature"},{"key":"805_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","volume":"18","author":"SE Antonarakis","year":"2017","unstructured":"Antonarakis SE. Down syndrome and the complexity of genome dosage imbalance. Nat Rev Genet. 2017;18:147\u201363. https:\/\/doi.org\/10.1038\/nrg.2016.154.","journal-title":"Nat Rev Genet"},{"key":"805_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gene.2013.07.055","volume":"530","author":"Y Xu","year":"2013","unstructured":"Xu Y, Li W, Liu X, Chen H, Tan K, Chen Y, et al. Identification of dysregulated microRNAs in lymphocytes from children with Down syndrome. Gene. 2013;530:278\u201386. https:\/\/doi.org\/10.1016\/j.gene.2013.07.055.","journal-title":"Gene"},{"key":"805_CR26","doi-asserted-by":"publisher","first-page":"7497","DOI":"10.18632\/oncotarget.7120","volume":"7","author":"CA Moreira-Filho","year":"2016","unstructured":"Moreira-Filho CA, et al. Modular transcriptional repertoire and microRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants. Oncotarget. 2016;7:7497\u2013533. https:\/\/doi.org\/10.18632\/oncotarget.7120.","journal-title":"Oncotarget"},{"key":"805_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4161\/rna.7.5.12685","volume":"7","author":"TS Elton","year":"2010","unstructured":"Elton TS, Sansom SE, Martin MM. Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins. RNA Biol. 2010;7:540\u20137. https:\/\/doi.org\/10.4161\/rna.7.5.12685.","journal-title":"RNA Biol"},{"key":"805_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ni.f.209","volume":"9","author":"D Baltimore","year":"2008","unstructured":"Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9:839\u201345. https:\/\/doi.org\/10.1038\/ni.f.209.","journal-title":"Nat Immunol"},{"key":"805_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/pd.2783","volume":"31","author":"J De Leon-Luis","year":"2011","unstructured":"De Leon-Luis J, et al. Sonographic thymic measurements in Down syndrome fetuses. Prenat Diagn. 2011;31:841\u20135. https:\/\/doi.org\/10.1002\/pd.2783.","journal-title":"Prenat Diagn"},{"key":"805_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1542\/peds.63.1.80","volume":"63","author":"S Levin","year":"1979","unstructured":"Levin S, Schlesinger M, Handzel Z, Hahn T, Altman Y, Czernobilsky B, et al. Thymic deficiency in Down\u2019s syndrome. Pediatrics. 1979;63:80\u20137.","journal-title":"Pediatrics"},{"key":"805_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0090-1229(90)90131-9","volume":"55","author":"M Murphy","year":"1990","unstructured":"Murphy M, Epstein LB. Down syndrome (trisomy 21) thymuses have a decreased proportion of cells expressing high levels of TCR alpha, beta and CD3. A possible mechanism for diminished T cell function in Down syndrome. Clinical immunology and immunopathology. 1990;55:453\u201367.","journal-title":"Clinical immunology and immunopathology"},{"key":"805_CR32","first-page":"225","volume":"7","author":"LM Larocca","year":"1990","unstructured":"Larocca LM, Lauriola L, Ranelletti FO, Piantelli M, Maggiano N, Ricci R, et al. Morphological and immunohistochemical study of down syndrome thymus. Am J Med Genet Suppl. 1990;7:225\u201330.","journal-title":"Am J Med Genet Suppl"},{"key":"805_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fimmu.2019.00447","volume":"10","author":"GE Marcovecchio","year":"2019","unstructured":"Marcovecchio GE, Bortolomai I, Ferrua F, Fontana E, Imberti L, Conforti E, et al. Thymic epithelium abnormalities in DiGeorge and down syndrome patients contribute to dysregulation in T cell development. Front Immunol. 2019;10:447. https:\/\/doi.org\/10.3389\/fimmu.2019.00447.","journal-title":"Front Immunol"},{"key":"805_CR34","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.4049\/jimmunol.1003053","volume":"187","author":"FA Lima","year":"2011","unstructured":"Lima FA, et al. Decreased AIRE expression and global thymic hypofunction in Down syndrome. Journal of immunology (Baltimore, Md. : 1950). 2011;187:3422\u201330. https:\/\/doi.org\/10.4049\/jimmunol.1003053.","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"805_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/cyto.b.21341","volume":"92","author":"E Ravkov","year":"2017","unstructured":"Ravkov E, Slev P, Heikal N. Thymic output: assessment of CD4(+) recent thymic emigrants and T-cell receptor excision circles in infants. Cytometry B Clin Cytom. 2017;92:249\u201357. https:\/\/doi.org\/10.1002\/cyto.b.21341.","journal-title":"Cytometry B Clin Cytom"},{"key":"805_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-4933-2-4","volume":"2","author":"N Prada","year":"2005","unstructured":"Prada N, Nasi M, Troiano L, Roat E, Pinti M, Nemes E, et al. Direct analysis of thymic function in children with Down\u2019s syndrome. Immun Ageing. 2005;2:4. https:\/\/doi.org\/10.1186\/1742-4933-2-4.","journal-title":"Immun Ageing"},{"key":"805_CR37","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1073\/pnas.070061597","volume":"97","author":"RD McFarland","year":"2000","unstructured":"McFarland RD, Douek DC, Koup RA, Picker LJ. Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci U S A. 2000;97:4215\u201320. https:\/\/doi.org\/10.1073\/pnas.070061597.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"805_CR38","doi-asserted-by":"publisher","unstructured":"Bloemers BL, et al. Decreased thymic output accounts for decreased naive T cell numbers in children with Down syndrome, Journal of immunology (Baltimore, Md. : 1950). 2011;186:4500\u20137. https:\/\/doi.org\/10.4049\/jimmunol.1001700.","DOI":"10.4049\/jimmunol.1001700"},{"key":"805_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaci.2013.04.024","volume":"132","author":"A Kwan","year":"2013","unstructured":"Kwan A, Church JA, Cowan MJ, Agarwal R, Kapoor N, Kohn DB, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol. 2013;132:140\u201350. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.024.","journal-title":"J Allergy Clin Immunol"},{"key":"805_CR40","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jaci.2013.10.010","volume":"133","author":"RH Verstegen","year":"2014","unstructured":"Verstegen RH, et al. Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases. J Allergy Clin Immunol. 2014;133:1208\u201311. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.010.","journal-title":"J Allergy Clin Immunol"},{"key":"805_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/0976-9668.159983","volume":"6","author":"G Mohiddin","year":"2015","unstructured":"Mohiddin G, et al. Oral Candidal and streptococcal carriage in Down syndrome patients. Journal of Natural Science, Biology, and Medicine. 2015;6:300\u20135. https:\/\/doi.org\/10.4103\/0976-9668.159983.","journal-title":"Journal of Natural Science, Biology, and Medicine"},{"key":"805_CR42","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1080\/08035250600771466","volume":"95","author":"A Soderbergh","year":"2006","unstructured":"Soderbergh A, et al. Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome. Acta paediatrica (Oslo, Norway : 1992). 2006;95:1657\u201360. https:\/\/doi.org\/10.1080\/08035250600771466.","journal-title":"Acta paediatrica (Oslo, Norway : 1992)"},{"key":"805_CR43","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.4049\/jimmunol.1400742","volume":"193","author":"G Skogberg","year":"2014","unstructured":"Skogberg G, et al. Altered expression of autoimmune regulator in infant down syndrome thymus, a possible contributor to an autoimmune phenotype.Journal of immunology (Baltimore, Md. : 1950). 2014;193:2187\u201395. https:\/\/doi.org\/10.4049\/jimmunol.1400742.","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"805_CR44","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.4049\/jimmunol.1400223","volume":"193","author":"M Gimenez-Barcons","year":"2014","unstructured":"Gimenez-Barcons M, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. Journal of immunology (Baltimore, Md. : 1950). 2014;193:3872\u20139. https:\/\/doi.org\/10.4049\/jimmunol.1400223.","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"805_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.2012.04610.x","volume":"169","author":"FP Pellegrini","year":"2012","unstructured":"Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, et al. Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol. 2012;169:238\u201343. https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04610.x.","journal-title":"Clin Exp Immunol"},{"key":"805_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178127","volume":"12","author":"A Muche","year":"2017","unstructured":"Muche A, Arendt T, Schliebs R. Oxidative stress affects processing of amyloid precursor protein in vascular endothelial cells. PLoS One. 2017;12:e0178127. https:\/\/doi.org\/10.1371\/journal.pone.0178127.","journal-title":"PLoS One"},{"key":"805_CR47","doi-asserted-by":"publisher","first-page":"724904","DOI":"10.1155\/2012\/724904","volume":"2012","author":"M Perluigi","year":"2012","unstructured":"Perluigi M, Butterfield DA. Oxidative stress and down syndrome: a route toward Alzheimer-like dementia. Curr Gerontol Geriatr Res. 2012;2012:724904\u201310. https:\/\/doi.org\/10.1155\/2012\/724904.","journal-title":"Curr Gerontol Geriatr Res"},{"key":"805_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bbadis.2011.12.010","volume":"1822","author":"IT Lott","year":"2012","unstructured":"Lott IT. Antioxidants in Down syndrome. Biochim Biophys Acta. 2012;1822:657\u201363. https:\/\/doi.org\/10.1016\/j.bbadis.2011.12.010.","journal-title":"Biochim Biophys Acta"},{"key":"805_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/imm.12092","volume":"139","author":"LP Lorenzo","year":"2013","unstructured":"Lorenzo LP, Shatynski KE, Clark S, Yarowsky PJ, Williams MS. Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome. Immunology. 2013;139:447\u201358. https:\/\/doi.org\/10.1111\/imm.12092.","journal-title":"Immunology"},{"key":"805_CR50","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.4049\/jimmunol.163.10.5399","volume":"163","author":"JE Paz-Miguel","year":"1999","unstructured":"Paz-Miguel JE, et al. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down\u2019s syndrome. Journal of immunology (Baltimore, Md. : 1950). 1999;163:5399\u2013410.","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"805_CR51","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jaut.2010.07.008","volume":"35","author":"SM Laakso","year":"2010","unstructured":"Laakso SM, Laurinolli TT, Rossi LH, Lehtoviita A, Sairanen H, Perheentupa J, et al. Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J Autoimmun. 2010;35:351\u20137. https:\/\/doi.org\/10.1016\/j.jaut.2010.07.008.","journal-title":"J Autoimmun"},{"key":"805_CR52","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/infdis\/jix168","volume":"215","author":"J Schoch","year":"2017","unstructured":"Schoch J, Rohrer TR, Kaestner M, Abdul-Khaliq H, Gortner L, Sester U, et al. Quantitative, phenotypical, and functional characterization of cellular immunity in children and adolescents with Down syndrome. J Infect Dis. 2017;215:1619\u201328. https:\/\/doi.org\/10.1093\/infdis\/jix168.","journal-title":"J Infect Dis"},{"key":"805_CR53","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2012.0514","volume":"23","author":"AB Glick","year":"2013","unstructured":"Glick AB, Wodzinski A, Fu P, Levine AD, Wald DN. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid : official journal of the American Thyroid Association. 2013;23:871\u20138. https:\/\/doi.org\/10.1089\/thy.2012.0514.","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"805_CR54","doi-asserted-by":"publisher","first-page":"24231","DOI":"10.1073\/pnas.1908129116","volume":"116","author":"P Araya","year":"2019","unstructured":"Araya P, Waugh KA, Sullivan KD, N\u00fa\u00f1ez NG, Roselli E, Smith KP, et al. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci U S A. 2019;116:24231\u201341. https:\/\/doi.org\/10.1073\/pnas.1908129116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"805_CR55","doi-asserted-by":"publisher","unstructured":"Lavaert M, Liang KL, Vandamme N, Park JE, Roels J, Kowalczyk MS, Li B, Ashenberg O, Tabaka M, Dionne D, Tickle TL, Slyper M, Rozenblatt-Rosen O, Vandekerckhove B, Leclercq G, Regev A, van Vlierberghe P, Guilliams M, Teichmann SA, Saeys Y, Taghon T. Integrated scRNA-Seq identifies human postnatal thymus seeding progenitors and regulatory dynamics of differentiating immature thymocytes. Immunity. 2020. https:\/\/doi.org\/10.1016\/j.immuni.2020.03.019.","DOI":"10.1016\/j.immuni.2020.03.019"},{"key":"805_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxy073","volume":"31","author":"J Wang","year":"2019","unstructured":"Wang J, Sekai M, Matsui T, Fujii Y, Matsumoto M, Takeuchi O, et al. Hassall's corpuscles with cellular-senescence features maintain IFN\u03b1 production through neutrophils and pDC activation in the thymus. Int Immunol. 2019;31:127\u201339. https:\/\/doi.org\/10.1093\/intimm\/dxy073.","journal-title":"Int Immunol"},{"key":"805_CR57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ni.2193","volume":"13","author":"AS Papadopoulou","year":"2011","unstructured":"Papadopoulou AS, Dooley J, Linterman MA, Pierson W, Ucar O, Kyewski B, et al. The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-\u03b1 receptor. Nat Immunol. 2011;13:181\u20137. https:\/\/doi.org\/10.1038\/ni.2193.","journal-title":"Nat Immunol"},{"key":"805_CR58","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jmg.34.10.798","volume":"34","author":"AK Ryan","year":"1997","unstructured":"Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798\u2013804. https:\/\/doi.org\/10.1136\/jmg.34.10.798.","journal-title":"J Med Genet"},{"key":"805_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00018-011-0842-z","volume":"69","author":"A Gennery","year":"2012","unstructured":"Gennery A. R. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci. 2012;69:17\u201327. https:\/\/doi.org\/10.1007\/s00018-011-0842-z.","journal-title":"Cell Mol Life Sci"},{"key":"805_CR60","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/ajmg.a.38319","volume":"173","author":"M Morsheimer","year":"2017","unstructured":"Morsheimer M, Brown Whitehorn TF, Heimall J, Sullivan KE. The immune deficiency of chromosome 22q11.2 deletion syndrome. Am J Med Genet A. 2017;173:2366\u201372. https:\/\/doi.org\/10.1002\/ajmg.a.38319.","journal-title":"Am J Med Genet A"},{"key":"805_CR61","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1067\/mpd.2001.118534","volume":"139","author":"AF Jawad","year":"2001","unstructured":"Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome\/velocardiofacial syndrome). J Pediatr. 2001;139:715\u201323. https:\/\/doi.org\/10.1067\/mpd.2001.118534.","journal-title":"J Pediatr"},{"key":"805_CR62","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1203\/PDR.0b013e3181d4ecc1","volume":"67","author":"RH Verstegen","year":"2010","unstructured":"Verstegen RH, Kusters MA, Gemen EF, De Vries E. Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res. 2010;67:563\u20139. https:\/\/doi.org\/10.1203\/PDR.0b013e3181d4ecc1.","journal-title":"Pediatr Res"},{"key":"805_CR63","doi-asserted-by":"publisher","first-page":"915864","DOI":"10.1155\/2011\/915864","volume":"2011","author":"NJ Halnon","year":"2011","unstructured":"Halnon NJ, Cooper P, Chen DY, Boechat MI, Uittenbogaart CH. Immune dysregulation after cardiothoracic surgery and incidental thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis. Clinical & developmental immunology. 2011;2011:915864\u201311. https:\/\/doi.org\/10.1155\/2011\/915864.","journal-title":"Clinical & developmental immunology"},{"key":"805_CR64","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1203\/01.Pdr.0000147735.19342.De","volume":"57","author":"NJ Halnon","year":"2005","unstructured":"Halnon NJ, Jamieson B, Plunkett M, Kitchen CMR, Pham T, Krogstad P. Thymic function and impaired maintenance of peripheral T cell populations in children with congenital heart disease and surgical thymectomy. Pediatr Res. 2005;57:42\u20138. https:\/\/doi.org\/10.1203\/01.Pdr.0000147735.19342.De.","journal-title":"Pediatr Res"},{"key":"805_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood-2011-03-341396","volume":"118","author":"R van Gent","year":"2011","unstructured":"van Gent R, Schadenberg AWL, Otto SA, Nievelstein RAJ, Sieswerda GT, Haas F, et al. Long-term restoration of the human T-cell compartment after thymectomy during infancy: a role for thymic regeneration? Blood. 2011;118:627\u201334. https:\/\/doi.org\/10.1182\/blood-2011-03-341396.","journal-title":"Blood"},{"key":"805_CR66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1203\/PDR.0b013e3181d4eca3","volume":"67","author":"MA Kusters","year":"2010","unstructured":"Kusters MA, Gemen EF, Verstegen RH, Wever PC, DE. Vries. E. Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes. Pediatr Res. 2010;67:557\u201362. https:\/\/doi.org\/10.1203\/PDR.0b013e3181d4eca3.","journal-title":"Pediatr Res"},{"key":"805_CR67","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","volume":"156","author":"MA Kusters","year":"2009","unstructured":"Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009;156:189\u201393. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03890.x.","journal-title":"Clin Exp Immunol"},{"key":"805_CR68","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jpeds.2005.07.022","volume":"147","author":"YC de Hingh","year":"2005","unstructured":"de Hingh YC, et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr. 2005;147:744\u20137. https:\/\/doi.org\/10.1016\/j.jpeds.2005.07.022.","journal-title":"J Pediatr"},{"key":"805_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0090-1229(92)90079-4","volume":"62","author":"M Murphy","year":"1992","unstructured":"Murphy M, Epstein LB. Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus. Clin Immunol Immunopathol. 1992;62:245\u201351.","journal-title":"Clin Immunol Immunopathol"},{"key":"805_CR70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-3083.1992.tb02859.x","volume":"35","author":"A Bertotto","year":"1992","unstructured":"Bertotto A, et al. Lymphocytes bearing the gamma\/delta T-cell receptors in Down\u2019s syndrome. Scand J Immunol. 1992;35:275\u20138.","journal-title":"Scand J Immunol"},{"key":"805_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1352\/2009.114.100-109","volume":"114","author":"L Guazzarotti","year":"2009","unstructured":"Guazzarotti L, Trabattoni D, Castelletti E, Boldrighini B, Piacentini L, Duca P, et al. T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome). Am J Intellect Dev Disabil. 2009;114:100\u20139. https:\/\/doi.org\/10.1352\/2009.114.100-109.","journal-title":"Am J Intellect Dev Disabil"},{"key":"805_CR72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1684\/ecn.2012.0307","volume":"23","author":"M Nateghi Rostami","year":"2012","unstructured":"Nateghi Rostami M, Douraghi M, Miramin Mohammadi A, Nikmanesh B. Altered serum pro-inflammatory cytokines in children with Down\u2019s syndrome. Eur Cytokine Netw. 2012;23:64\u20137. https:\/\/doi.org\/10.1684\/ecn.2012.0307.","journal-title":"Eur Cytokine Netw"},{"key":"805_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.10.048","volume":"395","author":"D Franciotta","year":"2006","unstructured":"Franciotta D, Verri A, Zardini E, Andreoni L, de Amici M, Moratti R, et al. Interferon-gamma- and interleukin-4-producing T cells in Down\u2019s syndrome. Neurosci Lett. 2006;395:67\u201370. https:\/\/doi.org\/10.1016\/j.neulet.2005.10.048.","journal-title":"Neurosci Lett"},{"key":"805_CR74","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.pharep.2015.04.008","volume":"67","author":"A Jakubiuk-Tomaszuk","year":"2015","unstructured":"Jakubiuk-Tomaszuk A, Sobaniec W, Rusak M, Poskrobko E, N\u0119dzi A, Olchowik B, et al. Decrease of interleukin (IL)17A gene expression in leucocytes and in the amount of IL-17A protein in CD4+ T cells in children with Down syndrome. Pharmacological reports : PR. 2015;67:1130\u20134. https:\/\/doi.org\/10.1016\/j.pharep.2015.04.008.","journal-title":"Pharmacological reports : PR"},{"key":"805_CR75","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621\u201363. https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101400.","journal-title":"Annu Rev Immunol"},{"key":"805_CR76","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/imr.12740","volume":"288","author":"W Song","year":"2019","unstructured":"Song W, Craft J. T follicular helper cell heterogeneity: time, space, and function. Immunol Rev. 2019;288:85\u201396. https:\/\/doi.org\/10.1111\/imr.12740.","journal-title":"Immunol Rev"},{"key":"805_CR77","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"50","author":"S Crotty","year":"2019","unstructured":"Crotty S. T follicular helper cell biology: a decade of discovery and diseases. Immunity. 2019;50:1132\u201348. https:\/\/doi.org\/10.1016\/j.immuni.2019.04.011.","journal-title":"Immunity"},{"key":"805_CR78","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1146\/annurev.immunol.26.021607.090344","volume":"26","author":"C King","year":"2008","unstructured":"King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol. 2008;26:741\u201366. https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090344.","journal-title":"Annu Rev Immunol"},{"key":"805_CR79","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.3389\/fimmu.2018.02683","volume":"9","author":"C Farroni","year":"2018","unstructured":"Farroni C, Marasco E, Marcellini V, Giorda E, Valentini D, Petrini S, et al. Dysregulated miR-155 and miR-125b are related to impaired B-cell responses in Down syndrome. Front Immunol. 2018;9:2683. https:\/\/doi.org\/10.3389\/fimmu.2018.02683.","journal-title":"Front Immunol"},{"key":"805_CR80","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10875-020-00755-0","volume":"40","author":"G Ottaviano","year":"2020","unstructured":"Ottaviano G, Gerosa J, Santini M, de Leo P, Vecchione A, Jofra T, et al. A prevalent CXCR3(+) phenotype of circulating follicular helper T cells indicates humoral dysregulation in children with Down syndrome. J Clin Immunol. 2020;40:447\u201355. https:\/\/doi.org\/10.1007\/s10875-020-00755-0.","journal-title":"J Clin Immunol"},{"key":"805_CR81","doi-asserted-by":"publisher","unstructured":"Foley C, Floudas A, Canavan M, Biniecka M, MacDermott EJ, Veale DJ, Mullan RH, Killeen OG, Fearon U. Increased T cell plasticity with dysregulation of T follicular helper, T peripheral helper and T regulatory cell responses in children with JIA and Down syndrome-associated arthritis. Arthritis rheumatol. 2019.\u00a0https:\/\/doi.org\/10.1002\/art.41150.","DOI":"10.1002\/art.41150"},{"key":"805_CR82","doi-asserted-by":"publisher","unstructured":"Sullivan KD et al. Trisomy 21 consistently activates the interferon response. eLife. 2016. https:\/\/doi.org\/10.7554\/eLife.16220.","DOI":"10.7554\/eLife.16220"},{"key":"805_CR83","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.celrep.2019.10.038","volume":"29","author":"KA Waugh","year":"2019","unstructured":"Waugh KA, et al. Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in Down syndrome. Cell reports. 2019;29:1893\u20131908.e1894. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.038.","journal-title":"Cell reports"},{"key":"805_CR84","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/107999000312612","volume":"20","author":"LE Maroun","year":"2000","unstructured":"Maroun LE, Heffernan TN, Hallam DM. Partial IFN-alpha\/beta and IFN-gamma receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viability. J Interf Cytokine Res. 2000;20:197\u2013203. https:\/\/doi.org\/10.1089\/107999000312612.","journal-title":"J Interf Cytokine Res"},{"key":"805_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2249.1990.tb05128.x","volume":"79","author":"S Raziuddin","year":"1990","unstructured":"Raziuddin S, Elawad ME. Immunoregulatory CD4+ CD45R+ suppressor\/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down\u2019s syndrome. Clin Exp Immunol. 1990;79:67\u201371.","journal-title":"Clin Exp Immunol"},{"key":"805_CR86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-3083.1989.tb01186.x","volume":"30","author":"A Bertotto","year":"1989","unstructured":"Bertotto A, et al. T-cell response to anti-CD2 monoclonal antibodies in Down\u2019s syndrome. Scand J Immunol. 1989;30:39\u201343.","journal-title":"Scand J Immunol"},{"key":"805_CR87","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/08820138709087092","volume":"16","author":"RL Noble","year":"1987","unstructured":"Noble RL, Warren RP. Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21). Immunol Investig. 1987;16:371\u201382.","journal-title":"Immunol Investig"},{"key":"805_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00273097","volume":"41","author":"A Serra","year":"1978","unstructured":"Serra A, Arpaia E, Bova R. Kinetics of 21-trisomic lymphocytes. I. In vitro response of 21-trisomic lymphocytes to PHA. Hum Genet. 1978;41:157\u201367.","journal-title":"Hum Genet"},{"key":"805_CR89","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1136\/adc.62.11.1148","volume":"62","author":"A Bertotto","year":"1987","unstructured":"Bertotto A, Arcangeli C, Crupi S, Marinelli I, Gerli R, Vaccaro R. T cell response to anti-CD3 antibody in Down\u2019s syndrome. Arch Dis Child. 1987;62:1148\u201351.","journal-title":"Arch Dis Child"},{"key":"805_CR90","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF00441815","volume":"148","author":"D Montagna","year":"1988","unstructured":"Montagna D, Maccario R, Ugazio AG, Nespoli L, Pedroni E, Faggiano P, et al. Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities. Eur J Pediatr. 1988;148:53\u20137.","journal-title":"Eur J Pediatr"},{"key":"805_CR91","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.4049\/jimmunol.136.5.1661","volume":"136","author":"R Philip","year":"1986","unstructured":"Philip R, et al. Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). Journal of immunology (Baltimore, Md. : 1950). 1986;136:1661\u20137.","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"805_CR92","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.humimm.2016.08.012","volume":"77","author":"J La\u0161\u0165ovi\u010dka","year":"2016","unstructured":"La\u0161\u0165ovi\u010dka J, Rataj M, Bart\u016f\u0148kov\u00e1 J. Assessment of lymphocyte proliferation for diagnostic purpose: comparison of CFSE staining, Ki-67 expression and (3)H-thymidine incorporation. Hum Immunol. 2016;77:1215\u201322. https:\/\/doi.org\/10.1016\/j.humimm.2016.08.012.","journal-title":"Hum Immunol"},{"key":"805_CR93","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3389\/fimmu.2019.02084","volume":"10","author":"RHJ Verstegen","year":"2019","unstructured":"Verstegen RHJ, Aui PM, Watson E, de Jong S, Bartol SJW, Bosco JJ, et al. Quantification of T-cell and B-cell replication history in aging, immunodeficiency, and newborn screening. Front Immunol. 2019;10:2084. https:\/\/doi.org\/10.3389\/fimmu.2019.02084.","journal-title":"Front Immunol"},{"key":"805_CR94","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.humimm.2016.05.004","volume":"77","author":"E Martinez","year":"2016","unstructured":"Martinez E, et al. Altered immune parameters correlate with infection-related hospitalizations in children with Down syndrome. Hum Immunol. 2016;77:594\u20139. https:\/\/doi.org\/10.1016\/j.humimm.2016.05.004.","journal-title":"Hum Immunol"},{"key":"805_CR95","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaci.2014.07.015","volume":"134","author":"RHJ Verstegen","year":"2014","unstructured":"Verstegen RHJ, et al. Defective B-cell memory in patients with Down syndrome. The Journal of allergy and clinical immunology. 2014;134:1346\u20131353.e1349. https:\/\/doi.org\/10.1016\/j.jaci.2014.07.015.","journal-title":"The Journal of allergy and clinical immunology"},{"key":"805_CR96","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5114\/ceji.2018.80042","volume":"43","author":"M Mitwalli","year":"2018","unstructured":"Mitwalli M, Wahba Y, Shaltout A, Gouida M. Lymphocyte subgroups and recurrent infections in children with Down syndrome - a prospective case control study. Central-European journal of immunology. 2018;43:248\u201354. https:\/\/doi.org\/10.5114\/ceji.2018.80042.","journal-title":"Central-European journal of immunology"},{"key":"805_CR97","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/eji.201445049","volume":"45","author":"R Carsetti","year":"2015","unstructured":"Carsetti R, Valentini D, Marcellini V, Scarsella M, Marasco E, Giustini F, et al. Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome. Eur J Immunol. 2015;45:903\u201314. https:\/\/doi.org\/10.1002\/eji.201445049.","journal-title":"Eur J Immunol"},{"key":"805_CR98","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10238-017-0457-2","volume":"18","author":"AN Seckin","year":"2018","unstructured":"Seckin AN, Ozdemir H, Ceylan A, Artac H. Age-related alterations of the CD19 complex and memory B cells in children with Down syndrome. Clin Exp Med. 2018;18:125\u201331. https:\/\/doi.org\/10.1007\/s10238-017-0457-2.","journal-title":"Clin Exp Med"},{"key":"805_CR99","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1651-2227.2012.02696.x","volume":"101","author":"CJ Broers","year":"2012","unstructured":"Broers CJ, et al. Frequency of lower respiratory tract infections in relation to adaptive immunity in children with Down syndrome compared to their healthy siblings. Acta paediatrica (Oslo, Norway : 1992). 2012;101:862\u20137. https:\/\/doi.org\/10.1111\/j.1651-2227.2012.02696.x.","journal-title":"Acta paediatrica (Oslo, Norway : 1992)"},{"key":"805_CR100","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mrfmmm.2007.07.010","volume":"637","author":"Z Morawiec","year":"2008","unstructured":"Morawiec Z, Janik K, Kowalski M, Stetkiewicz T, Szaflik J, Morawiec-Bajda A, et al. DNA damage and repair in children with Down\u2019s syndrome. Mutat Res. 2008;637:118\u201323. https:\/\/doi.org\/10.1016\/j.mrfmmm.2007.07.010.","journal-title":"Mutat Res"},{"key":"805_CR101","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaci.2013.01.053","volume":"131","author":"GJ Driessen","year":"2013","unstructured":"Driessen GJ, et al. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. The Journal of allergy and clinical immunology. 2013;131:1367\u20131375.e1369. https:\/\/doi.org\/10.1016\/j.jaci.2013.01.053.","journal-title":"The Journal of allergy and clinical immunology"},{"key":"805_CR102","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1182\/blood-2009-10-250514","volume":"115","author":"M van der Burg","year":"2010","unstructured":"van der Burg M, Pac M, Berkowska MA, Goryluk-Kozakiewicz B, Wakulinska A, Dembowska-Baginska B, et al. Loss of juxtaposition of RAG-induced immunoglobulin DNA ends is implicated in the precursor B-cell differentiation defect in NBS patients. Blood. 2010;115:4770\u20137. https:\/\/doi.org\/10.1182\/blood-2009-10-250514.","journal-title":"Blood"},{"key":"805_CR103","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/pbc.24246","volume":"59","author":"EF Gemen","year":"2012","unstructured":"Gemen EF, Verstegen RH, Leuvenink J, de Vries E. Increased circulating apoptotic lymphocytes in children with Down syndrome. Pediatr Blood Cancer. 2012;59:1310\u20132. https:\/\/doi.org\/10.1002\/pbc.24246.","journal-title":"Pediatr Blood Cancer"},{"key":"805_CR104","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/ar2076","volume":"8","author":"T Vallerskog","year":"2006","unstructured":"Vallerskog T, Heimb\u00fcrger M, Gunnarsson I, Zhou W, Wahren-Herlenius M, Trollmo C, et al. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther. 2006;8:R167. https:\/\/doi.org\/10.1186\/ar2076.","journal-title":"Arthritis Res Ther"},{"key":"805_CR105","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1471-2164-8-268","volume":"8","author":"A Conti","year":"2007","unstructured":"Conti A, Fabbrini F, D'Agostino P, Negri R, Greco D, Genesio R, et al. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genomics. 2007;8:268. https:\/\/doi.org\/10.1186\/1471-2164-8-268.","journal-title":"BMC Genomics"},{"key":"805_CR106","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","volume":"17","author":"P Helguera","year":"2013","unstructured":"Helguera P, Seiglie J, Rodriguez J, Hanna M, Helguera G, Busciglio J. Adaptive downregulation of mitochondrial function in Down syndrome. Cell Metab. 2013;17:132\u201340. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.005.","journal-title":"Cell Metab"},{"key":"805_CR107","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.tiv.2009.12.012","volume":"24","author":"G Dogliotti","year":"2010","unstructured":"Dogliotti G, Galliera E, Dozio E, Vianello E, Villa RE, Licastro F, et al. Okadaic acid induces apoptosis in Down syndrome fibroblasts. Toxicology in vitro: an international journal published in association with BIBRA. 2010;24:815\u201321. https:\/\/doi.org\/10.1016\/j.tiv.2009.12.012.","journal-title":"Toxicology in vitro: an international journal published in association with BIBRA"},{"key":"805_CR108","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.febslet.2006.12.058","volume":"581","author":"E Roat","year":"2007","unstructured":"Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L, et al. Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett. 2007;581:521\u20135. https:\/\/doi.org\/10.1016\/j.febslet.2006.12.058.","journal-title":"FEBS Lett"},{"key":"805_CR109","doi-asserted-by":"publisher","unstructured":"Chou J, Alazami AM, Jaber F, Hoyos-Bachiloglu R, Jones J, Weeks S, et al. Hypomorphic variants in AK2 reveal the contribution of mitochondrial function to B-cell activation. J Allergy Clin Immunol. 2019. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.004.","DOI":"10.1016\/j.jaci.2019.12.004"},{"key":"805_CR110","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1182\/blood-2011-04-345579","volume":"118","author":"MA Berkowska","year":"2011","unstructured":"Berkowska MA, Driessen GJA, Bikos V, Grosserichter-Wagener C, Stamatopoulos K, Cerutti A, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood. 2011;118:2150\u20138. https:\/\/doi.org\/10.1182\/blood-2011-04-345579.","journal-title":"Blood"},{"key":"805_CR111","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1002\/eji.201242683","volume":"42","author":"H von Bernuth","year":"2012","unstructured":"von Bernuth H, Picard C, Puel A, Casanova JL. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans. Eur J Immunol. 2012;42:3126\u201335. https:\/\/doi.org\/10.1002\/eji.201242683.","journal-title":"Eur J Immunol"},{"key":"805_CR112","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2012-07-440776","volume":"120","author":"S Weller","year":"2012","unstructured":"Weller S, Bonnet M, Delagreverie H, Israel L, Chrabieh M, Mar\u00f3di L, et al. IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients. Blood. 2012;120:4992\u20135001. https:\/\/doi.org\/10.1182\/blood-2012-07-440776.","journal-title":"Blood"},{"key":"805_CR113","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.immuni.2008.09.015","volume":"29","author":"I Isnardi","year":"2008","unstructured":"Isnardi I, Ng YS, Srdanovic I, Motaghedi R, Rudchenko S, von Bernuth H, et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity. 2008;29:746\u201357. https:\/\/doi.org\/10.1016\/j.immuni.2008.09.015.","journal-title":"Immunity"},{"key":"805_CR114","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaci.2013.11.015","volume":"134","author":"MC van Zelm","year":"2014","unstructured":"van Zelm MC, Bartol SJW, Driessen GJ, Mascart F, Reisli I, Franco JL, et al. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin Immunol. 2014;134:135\u201344. https:\/\/doi.org\/10.1016\/j.jaci.2013.11.015.","journal-title":"J Allergy Clin Immunol"},{"key":"805_CR115","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann H, et al. Predominant autoantibody production by early human B cell precursors. Science (New York, N.Y.). 2003;301:1374\u20137. https:\/\/doi.org\/10.1126\/science.1086907.","journal-title":"Science (New York, N.Y.)"},{"key":"805_CR116","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1172\/JCI12462","volume":"108","author":"AE Pugh-Bernard","year":"2001","unstructured":"Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, Insel RA, et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest. 2001;108:1061\u201370. https:\/\/doi.org\/10.1172\/JCI12462.","journal-title":"J Clin Invest"},{"key":"805_CR117","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.3389\/fimmu.2018.02545","volume":"9","author":"PA van Schouwenburg","year":"2018","unstructured":"van Schouwenburg PA, IJspeert H, Pico-Knijnenburg I, Dalm VASH, van Hagen PM, van Zessen D, et al. Identification of CVID patients with defects in immune repertoire formation or specification. Front Immunol. 2018;9:2545. https:\/\/doi.org\/10.3389\/fimmu.2018.02545.","journal-title":"Front Immunol"},{"key":"805_CR118","doi-asserted-by":"publisher","unstructured":"Alivernini S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nature communications. 2016;(7):12970. https:\/\/doi.org\/10.1038\/ncomms12970.","DOI":"10.1038\/ncomms12970"},{"key":"805_CR119","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1126\/science.1139253","volume":"316","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A, et al. Requirement of bic\/microRNA-155 for normal immune function. Science (New York, N.Y.). 2007;316:608\u201311. https:\/\/doi.org\/10.1126\/science.1139253.","journal-title":"Science (New York, N.Y.)"},{"key":"805_CR120","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","volume":"115","author":"I Isnardi","year":"2010","unstructured":"Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, et al. Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010;115:5026\u201336. https:\/\/doi.org\/10.1182\/blood-2009-09-243071.","journal-title":"Blood"},{"key":"805_CR121","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.clim.2004.05.010","volume":"113","author":"C Wehr","year":"2004","unstructured":"Wehr C, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clinical immunology (Orlando, Fla.). 2004;113:161\u201371. https:\/\/doi.org\/10.1016\/j.clim.2004.05.010.","journal-title":"Clinical immunology (Orlando, Fla.)"},{"key":"805_CR122","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","volume":"141","author":"S Unger","year":"2018","unstructured":"Unger S, Seidl M, van Schouwenburg P, Rakhmanov M, Bulashevska A, Frede N, et al. The TH1 phenotype of follicular helper T cells indicates an IFN-gamma-associated immune dysregulation in patients with CD21low common variable immunodeficiency. J Allergy Clin Immunol. 2018;141:730\u201340. https:\/\/doi.org\/10.1016\/j.jaci.2017.04.041.","journal-title":"J Allergy Clin Immunol"},{"key":"805_CR123","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13023-018-0941-0","volume":"13","author":"I Odnoletkova","year":"2018","unstructured":"Odnoletkova I, et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13:201. https:\/\/doi.org\/10.1186\/s13023-018-0941-0.","journal-title":"Orphanet J Rare Dis"},{"key":"805_CR124","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1016\/j.vaccine.2015.10.083","volume":"33","author":"D Valentini","year":"2015","unstructured":"Valentini D, Marcellini V, Bianchi S, Villani A, Facchini M, Donatelli I, et al. Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings. Vaccine. 2015;33:6689\u201396. https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.083.","journal-title":"Vaccine"},{"key":"805_CR125","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/cch.12099","volume":"40","author":"R Nisihara","year":"2014","unstructured":"Nisihara R, de Bem RS, Negreiros PHR, Utiyama SRR, Oliveira NP, Amarante H. Low hepatitis B vaccine response in children with Down syndrome from Brazil. Child Care Health Dev. 2014;40:607\u20139. https:\/\/doi.org\/10.1111\/cch.12099.","journal-title":"Child Care Health Dev"},{"key":"805_CR126","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/hep.1840040406","volume":"4","author":"RA Heijtink","year":"1984","unstructured":"Heijtink RA, De Jong P, Schalm SW, Masurel N. Hepatitis B vaccination in Down\u2019s syndrome and other mentally retarded patients. Hepatology (Baltimore, Md.). 1984;4:611\u20134.","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"805_CR127","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/pai.12796","volume":"28","author":"NB Eijsvoogel","year":"2017","unstructured":"Eijsvoogel NB, Hollegien MI, Bok LA, Derksen-Lubsen G, Dikken FPJ, Leenders ACAP, et al. Lower percentage of allergic sensitization in children with Down syndrome. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2017;28:852\u20137. https:\/\/doi.org\/10.1111\/pai.12796.","journal-title":"Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology"},{"key":"805_CR128","first-page":"231","volume":"7","author":"M Avanzini","year":"1990","unstructured":"Avanzini M, et al. Humoral immunodeficiency in Down syndrome: serum IgG subclass and antibody response to hepatitis B vaccine. American Journal Medical Genetics. 1990;7:231\u20133.","journal-title":"American Journal Medical Genetics"},{"key":"805_CR129","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157\u201367. https:\/\/doi.org\/10.1056\/NEJMra035092.","journal-title":"N Engl J Med"},{"issue":"Pt 1","key":"805_CR130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2788.1992.tb00472.x","volume":"36","author":"P Vajro","year":"1992","unstructured":"Vajro P, et al. Vaccination against hepatitis B in preschool children with Down\u2019s syndrome. Journal of intellectual disability research : JIDR. 1992;36(Pt 1):77\u201381.","journal-title":"Journal of intellectual disability research : JIDR"},{"key":"805_CR131","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1001\/jama.1985.03360220062029","volume":"254","author":"CL Troisi","year":"1985","unstructured":"Troisi CL, Heiberg DA, Hollinger FB. Normal immune response to hepatitis B vaccine in patients with Down\u2019s syndrome. A basis for immunization guidelines. Jama. 1985;254:3196\u20139.","journal-title":"Jama"},{"key":"805_CR132","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1016\/j.vaccine.2013.09.070","volume":"31","author":"MA Kusters","year":"2013","unstructured":"Kusters MA, et al. Functionality of the pneumococcal antibody response in Down syndrome subjects. Vaccine. 2013;31:6261\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.070.","journal-title":"Vaccine"},{"key":"805_CR133","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/INF.0b013e3181ff85a8","volume":"30","author":"MA Kusters","year":"2011","unstructured":"Kusters MA, Jol-van der Zijde CM, van Tol MJ, Bolz WE, Bok LA, Visser M, et al. Impaired avidity maturation after tetanus toxoid booster in children with Down syndrome. Pediatr Infect Dis J. 2011;30:357\u20139. https:\/\/doi.org\/10.1097\/INF.0b013e3181ff85a8.","journal-title":"Pediatr Infect Dis J"},{"key":"805_CR134","doi-asserted-by":"crossref","unstructured":"de Hingh, Y. C., PhD et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome.Journal of Pediatrics 147, 744\u2013747 (2005).","DOI":"10.1016\/j.jpeds.2005.07.022"},{"key":"805_CR135","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1182\/blood.V77.6.1263.1263","volume":"77","author":"A Cossarrizza","year":"1991","unstructured":"Cossarrizza A. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down\u2019s syndrome. Blood. 1991;77:1263\u201370.","journal-title":"Blood"},{"key":"805_CR136","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/eji.1830050904","volume":"5","author":"G Burgio","year":"1975","unstructured":"Burgio G, et al. Derangements of immunoglobuline levels, phytohemagglutinin responsiveness and T and B cell markers in Down\u2019s syndrome at different ages. Eur J Immunol. 1975;5:600\u20133.","journal-title":"Eur J Immunol"},{"key":"805_CR137","first-page":"204","volume":"7","author":"A Ugazio","year":"1990","unstructured":"Ugazio A, Maccario R, Notarangelo L, Burgio G. Immunology of Down syndrome: a review. American Journal Medical Genetics supplement. 1990;7:204\u201312.","journal-title":"American Journal Medical Genetics supplement"},{"key":"805_CR138","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2788.1993.tb00324.x","volume":"37","author":"L Nespoli","year":"1993","unstructured":"Nespoli L, Burgio G, Ugazio A, Maccario R. Immunological features of Down\u2019s syndrome: a review. J Intellect Disabil Res. 1993;37:543\u201351.","journal-title":"J Intellect Disabil Res"},{"key":"805_CR139","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/00006454-199008000-00004","volume":"9","author":"RK Loh","year":"1990","unstructured":"Loh RK, Harth SC, Thong YH, Ferrante A. Immunoglobulin G subclass deficiency and predisposition to infection in Down\u2019s syndrome. Pediatr Infect Dis J. 1990;9:547\u201351.","journal-title":"Pediatr Infect Dis J"},{"key":"805_CR140","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/adc.67.5.628","volume":"67","author":"G Anneren","year":"1992","unstructured":"Anneren G, Magnusson CG, Lilja G, Nordvall SL. Abnormal serum IgG subclass pattern in children with Down\u2019s syndrome. Arch Dis Child. 1992;67:628\u201331.","journal-title":"Arch Dis Child"},{"key":"805_CR141","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/clim.2000.4834","volume":"95","author":"E Park","year":"2000","unstructured":"Park E, et al. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down\u2019s syndrome. Clinical immunology (Orlando, Fla.). 2000;95:62\u20139. https:\/\/doi.org\/10.1006\/clim.2000.4834.","journal-title":"Clinical immunology (Orlando, Fla.)"},{"key":"805_CR142","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00477543","volume":"124","author":"R Seger","year":"1977","unstructured":"Seger R, Buchinger G, Stroder J. On the influence of age on immunity in Down\u2019s syndrome. Eur J Pediatr. 1977;124:77\u201387.","journal-title":"Eur J Pediatr"},{"key":"805_CR143","doi-asserted-by":"publisher","unstructured":"Weijerman ME, Brand PL, van Furth MA, Broers CJ, Gemke RJ. Recurrent wheeze in children with Down syndrome: is it asthma? Acta paediatrica. 2011;100:e194\u2013197. https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02367.x.","DOI":"10.1111\/j.1651-2227.2011.02367.x"},{"key":"805_CR144","doi-asserted-by":"publisher","unstructured":"Mannan SE, Yousef E, Hossain J. Prevalence of positive skin prick test results in children with Down syndrome: a case-control study. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2009;102:205\u20139. https:\/\/doi.org\/10.1016\/s1081-1206(10)60082-8.","DOI":"10.1016\/s1081-1206(10)60082-8"},{"key":"805_CR145","first-page":"298","volume":"31","author":"RA Hawkes","year":"1978","unstructured":"Hawkes RA, Boughton CR, Schroeter DR. The antibody response of institutionalized Down\u2019s syndrome patients to seven microbial antigens. Clin Exp Immunol. 1978;31:298\u2013304.","journal-title":"Clin Exp Immunol"},{"key":"805_CR146","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1017\/s0022172400026978","volume":"84","author":"RA Hawkes","year":"1980","unstructured":"Hawkes RA, Philbrook SC, Boughton CR. The response of institutionalized Down\u2019s syndrome subjects to enterovirus infections. J Hyg. 1980;84:433\u201341. https:\/\/doi.org\/10.1017\/s0022172400026978.","journal-title":"J Hyg"},{"key":"805_CR147","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF00819505","volume":"12","author":"S Li Volti","year":"1996","unstructured":"Li Volti S, Mattina T, Mauro L, Bianca S, Anfuso S, Ursino A, et al. Safety and effectiveness of an acellular pertussis vaccine in subjects with Down\u2019s syndrome. Child\u2019s nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery. 1996;12:100\u20132.","journal-title":"Child\u2019s nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery"},{"key":"805_CR148","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00005176-200410000-00007","volume":"39","author":"C Ferreira","year":"2004","unstructured":"Ferreira C, et al. Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome. J Pediatr Gastroenterol Nutr. 2004;39:337\u201340.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"805_CR149","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/INF.0b013e31822233f9","volume":"30","author":"MA Kusters","year":"2011","unstructured":"Kusters MA, Jol-Van Der Zijde EC, Gijsbers RH, de Vries E. Decreased response after conjugated meningococcal serogroup C vaccination in children with Down syndrome. Pediatr Infect Dis J. 2011;30:818\u20139. https:\/\/doi.org\/10.1097\/INF.0b013e31822233f9.","journal-title":"Pediatr Infect Dis J"},{"key":"805_CR150","first-page":"485","volume":"48","author":"T Nurmi","year":"1982","unstructured":"Nurmi T, Leinonen M, Haiva VM, Tiilikainen A, Kouvalainen K. Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down\u2019s syndrome). Clin Exp Immunol. 1982;48:485\u201390.","journal-title":"Clin Exp Immunol"},{"key":"805_CR151","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1590\/S0100-879X2006001200010","volume":"39","author":"B Costa-Carvalho","year":"2006","unstructured":"Costa-Carvalho B, et al. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Brazilian Journal of medical Biology Research. 2006;39:1587\u201392.","journal-title":"Brazilian Journal of medical Biology Research"},{"key":"805_CR152","unstructured":"Verstegen RH. J. Humoral immunity in children with Down syndrome - relevance to respiratory disease (PhD thesis). 2014. http:\/\/hdl.handle.net\/1765\/77471."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00805-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00805-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00805-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T12:30:45Z","timestamp":1723206645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00805-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":152,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["805"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00805-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}